Quoin Pharmaceuticals Ltd. (QNRX) Form 10-K Annual Reports
Quoin Pharmaceuticals Ltd. (QNRX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: QNRX
CIK: 1671502
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
State: L3
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerMichael Cohen
Audit LocationMorristown, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-14 | 2026-10-14 | FORM 8-K | 0001104659-26-115709 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-10-07 | — | SCHEDULE 13G/A Filing | 0001778253-26-000004 | View SEC Doc Filr Page |
| DEF 14A | 2026-10-02 | 2026-11-12 | DEF 14A | 0001104659-26-113301 | View SEC Doc Filr Page |
| EFFECT | 2026-09-25 | — | EFFECT Filing | 9999999995-26-003071 | View SEC Doc Filr Page |
| 424B3 | 2026-09-25 | — | 424B3 | 0001104659-26-111012 | View SEC Doc Filr Page |
| PRE 14A | 2026-09-22 | 2026-11-12 | PRE 14A | 0001104659-26-109641 | View SEC Doc Filr Page |
| 8-K | 2026-09-22 | 2026-09-22 | FORM 8-K | 0001104659-26-109639 | View SEC Doc Filr Page |
| S-3 | 2026-09-18 | — | FORM S-3 | 0001104659-26-108970 | View SEC Doc Filr Page |
| D | 2026-09-10 | — | D Filing | 0001104659-26-106751 | View SEC Doc Filr Page |
| 8-K | 2026-09-10 | 2026-09-08 | FORM 8-K | 0001104659-26-106705 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-31 | OWNERSHIP DOCUMENT | 0001104659-26-104405 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-31 | OWNERSHIP DOCUMENT | 0001104659-26-104404 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-31 | OWNERSHIP DOCUMENT | 0001104659-26-104403 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-31 | OWNERSHIP DOCUMENT | 0001104659-26-104402 | View SEC Doc Filr Page |
| 4 | 2026-08-28 | 2026-08-27 | OWNERSHIP DOCUMENT | 0001104659-26-103376 | View SEC Doc Filr Page |
| 4 | 2026-08-28 | 2026-08-27 | OWNERSHIP DOCUMENT | 0001104659-26-103374 | View SEC Doc Filr Page |
| 8-K | 2026-08-28 | 2026-08-27 | FORM 8-K | 0001104659-26-102917 | View SEC Doc Filr Page |
| 8-K | 2026-08-20 | 2026-08-20 | FORM 8-K | 0001104659-26-099239 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | FORM 8-K | 0001104659-26-097094 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001104659-26-097064 | View SEC Doc Filr Page |
| ARS | 2026-07-16 | 2025-12-31 | ARS | 0001104659-26-084081 | View SEC Doc Filr Page |
| DEF 14A | 2026-07-16 | 2026-08-20 | DEF 14A | 0001104659-26-084078 | View SEC Doc Filr Page |
| PRE 14A | 2026-07-06 | 2026-08-20 | FORM PRE 14A | 0001104659-26-080828 | View SEC Doc Filr Page |
| 8-K | 2026-06-23 | 2026-06-23 | FORM 8-K | 0001104659-26-076822 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-06-04 | 8-K | 0001104659-26-070501 | View SEC Doc Filr Page |